Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Discussion: Additional treatment options impact first-line treatment of mRCC

Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán

Discussion: Additional treatment options impact first-line treatment of mRCC ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )

Additional treatment options impact first-line treatment of mRCC: Yes

Prof Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium

Additional treatment options impact first-line treatment of mRCC: Yes ( Prof Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )

What have we learned? Expert perspectives

Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán

What have we learned? Expert perspectives ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )

From clinical trial to clinical practice: Evidence from the real world

Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid...

From clinical trial to clinical practice: Evidence from the real world ( Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid, Madrid, Spain )

Navigating current treatment options for HER2-positive MBC: Patient journey 1

Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria

Navigating current treatment options for HER2-positive MBC: Patient journey 1 ( Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria )

ecancermedicalscience editor's choice for September 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience editor's choice for September 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Overview of skin cancer treatments, past, present and future

Prof John Hawk - President of the World Congress on Cancers of the Skin 2014

Overview of skin cancer treatments, past, present and future ( Prof John Hawk - President of the World Congress on Cancers of the Skin 2014 )

Advances in CLL: Expert panel Discussion

Prof Robin Foà ; Prof Clemens Wendtner; Dr Francesc Bosch; Prof Florence...

Advances in CLL: Expert panel Discussion ( Prof Robin Foà ; Prof Clemens Wendtner; Dr Francesc Bosch; Prof Florence Cymbalista )

Emerging treatments in CLL: Expert Discussion

Prof Robin Foà and Prof Peter Hillmen

Emerging treatments in CLL: Expert Discussion ( Prof Robin Foà and Prof Peter Hillmen )

Thrombosis in adult patients with chronic ITP

Dr Howard Liebman - University of Southern California, Los Angeles, USA

Thrombosis in adult patients with chronic ITP ( Dr Howard Liebman - University of Southern California, Los Angeles, USA )

Hot topic: B-cell depletion in adult chronic ITP

Dr Francesco Zaja - University of Udine, Udine, Italy

Hot topic: B-cell depletion in adult chronic ITP ( Dr Francesco Zaja - University of Udine, Udine, Italy )

Treatment options in adult chronic idiopathic thrombocytopenic purpura:...

Prof Aristoteles Giagounidis - St John’s Hospital, Duisburg, Germany

Treatment options in adult chronic idiopathic thrombocytopenic purpura: Introduction ( Prof Aristoteles Giagounidis - St John’s Hospital, Duisburg, Germany )

More from ecancer